Skip to content
★ Sign in to follow
Little Green Pharma Ltd logo

Little Green Pharma Ltd Stock: price and insider trades · Australia

ISIN AU0000074924AU·Mcap A$53.8MHealth Care

Little Green Pharma Ltd: what insiders have been doing

Little Green Pharma Ltd is a Health Care company. Its directors and officers file their transactions with ASX. The last twelve months, up to 24 October 2026, brought 6 filings signed by 6 insiders.

All open-market trades in the period are sales: 2 sales worth €779, by 2 insiders, with no purchase on record. The totals do not cover 1 filing with an undisclosed amount. The largest single trade was a sale of €779 by Fleta Jennifer Solomon, published on 31 May 2026.

For context, the typical company on the same exchange (median of 1,596 companies) published 4 filings over the same period, against 6 filings here. Since 2026, the database holds no purchases and 2 sales by insiders of the company.

The median gap between a trade and its publication by ASX is 7 days. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€779
2 ops. · all time

Who traded when

BuySale
Fleta Jennifer Solomon1 sale
Michael David Lynch-Bell1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,388 of 26,912 companies
42.1
score / 100
Value
25
Quality
59
FCF yld-1.8%
Earn yld-2.6%
EV/EBITDA21.5x
ROE14%
Gross mgn71%
Net mgn-3.3%
Debt/EBITDA1.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

A$0.07
Analyst consensus
1 analysts
2.00/5
A$0.15Target A$0.15(+131%)A$0.15
Income statement
RevenueA$42.4M
Gross profitA$30.1M71% margin
EBITDAA$2.7M6% margin
Net income-A$1.4M4.2% margin
Valuation
PER (forward)9.3x
P/Book0.3x
Beta0.30
Balance sheet & cash
Market capA$53.8M
Total debtA$4.7M
Free Cash Flow-A$960k
Profitability & ownership
ROE14.0%
ROA8.3%
% insiders8.7%
% institutions7.5%
Last declaration on 15 June 2026
Declarations6 total

6 of 6 declarations

About Little Green Pharma Ltd

Little Green Pharma Ltd is an Australian company focused on the production of cannabis-based medicines. It is listed on the Australian Securities Exchange (XASX).

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations